Advertisement
UK markets close in 2 hours 35 minutes
  • FTSE 100

    8,134.88
    -31.88 (-0.39%)
     
  • FTSE 250

    20,192.09
    -29.99 (-0.15%)
     
  • AIM

    763.98
    -1.20 (-0.16%)
     
  • GBP/EUR

    1.1802
    +0.0028 (+0.24%)
     
  • GBP/USD

    1.2669
    +0.0020 (+0.16%)
     
  • Bitcoin GBP

    49,566.68
    +6.89 (+0.01%)
     
  • CMC Crypto 200

    1,343.44
    -1.07 (-0.08%)
     
  • S&P 500

    5,475.09
    +14.61 (+0.27%)
     
  • DOW

    39,169.52
    +50.66 (+0.13%)
     
  • CRUDE OIL

    84.28
    +0.90 (+1.08%)
     
  • GOLD FUTURES

    2,334.70
    -4.20 (-0.18%)
     
  • NIKKEI 225

    40,074.69
    +443.63 (+1.12%)
     
  • HANG SENG

    17,769.14
    +50.53 (+0.29%)
     
  • DAX

    18,067.83
    -222.83 (-1.22%)
     
  • CAC 40

    7,507.06
    -54.07 (-0.72%)
     

Zacks.com featured highlights include: G-III, Vitamin Shoppe, Tech Data and Smart & Final

The Zacks Analyst Blog Highlights: Under Armour, G-III, Ralph Lauren and Columbia Sportswear

 

For Immediate Release

Chicago, IL – April 3, 2019 - Stocks in this week’s article are G-III Apparel Group, Ltd. GIII, Vitamin Shoppe, Inc. VSI, Tech Data Corp. TECD, Israel Chemicals Ltd. ICL and Smart & Final Stores, Inc. SFS.

Pick These 5 Bargain Stocks with Enticing EV/EBITDA Ratios

The price-to-earnings (P/E) ratio is widely considered by investors as a yardstick for evaluating the fair market value of a stock. It is preferred by many investors to handpick stocks trading at attractive prices. However, even this universally used valuation multiple is not without its limitations.

ADVERTISEMENT

Is EV/EBITDA a Better Alternative to P/E?

While P/E is hands down the most popular equity valuation ratio, there is another metric called EV/EBITDA that works even better in finding value stocks. This ratio is often viewed as a better substitute to P/E as it offers a clearer picture of a company’s valuation and earning potential. EV/EBITDA, also referred to as enterprise multiple, determines the total value of a firm while P/E considers just its equity portion.

EV/EBITDA is the enterprise value (EV) of a stock divided by its earnings before interest, taxes, depreciation and amortization (EBITDA). EV is the sum of a company’s market capitalization, its debt and preferred stock minus cash and cash equivalents. Simply put, it is the total value of a firm.

The other component, EBITDA gives the true picture of a firm’s profitability as it removes the impact of non-cash expenses like depreciation and amortization that dilute net earnings.

Typically, the lower the EV/EBITDA ratio, the more attractive it is. A low EV/EBITDA ratio could signal that a stock is potentially undervalued and vice versa.

However, unlike P/E ratio, EV/EBITDA takes into account the debt on a company’s balance sheet. For this reason, EV/EBITDA is usually used to value possible acquisition targets. Stocks with a low EV/EBITDA multiple could be seen as potential takeover candidates.

Another downside of P/E is that it can’t be used to value a loss-making company. A company’s earnings are also subject to accounting estimates and management manipulation. EV/EBITDA, in contrast, is less amenable to manipulation and also can be used to value firms that have negative net earnings but are positive on the EBITDA side.

Moreover, EV/EBITDA allows the comparison of companies with different debt levels and is a useful tool in measuring the value of firms that are highly leveraged and have substantial depreciation and amortization expenses.

However, EV/EBITDA is also not without its shortcomings and alone cannot conclusively determine a stock’s inherent potential and future performance. The ratio varies across industries and is generally not appropriate while comparing stocks in different industries given their diverse capital spending requirements.

As such, a strategy solely based on EV/EBITDA might not yield the desired results.  But you can club it with the other major ratios in your stock investing toolbox such as price-to-book (P/B), P/E and price-to-sales (P/S) to screen bargain stocks.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/369048/pick-these-5-bargain-stocks-with-enticing-evebitda-ratios

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>. 

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

 Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: www.Zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Israel Chemicals Shs (ICL) : Free Stock Analysis Report
 
Vitamin Shoppe, Inc (VSI) : Free Stock Analysis Report
 
Smart (SFS) : Free Stock Analysis Report
 
Tech Data Corporation (TECD) : Free Stock Analysis Report
 
G-III Apparel Group, LTD. (GIII) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.